What is the Share Price of Ishita Drugs Industries Ltd?

Ishita Drugs Industries Ltd share price is ₹71.72 As on 17 November, 2024|21:30

Home
>
Stocks
>
Ishita Drugs Industries Ltd

Ishita Drugs Industries Ltd Share/Stock Price

Q: What is the Market Cap of Ishita Drugs Industries Ltd?

The Market Cap of Ishita Drugs Industries Ltd is ₹21.4 As on 17 November, 2024|21:30

Q: What is PE Ratio of Ishita Drugs Industries Ltd?

The P/E ratio of Ishita Drugs Industries Ltd is 29 As on 17 November, 2024|21:30

Q: What is PB Ratio of Ishita Drugs Industries Ltd?

The PB ratio of Ishita Drugs Industries Ltd is 2.09 As on 17 November, 2024|21:30

₹ 0 (%)
Updated on 01-01-1970 5:30 AM

Stock Rating

BSE

Pros 2

Cons 5

Ishita Drugs Industries Ltd Price Performance

Day's Low
₹0

Day's High
₹0

₹ 0

52-w low
₹0

52-w high
₹0

Day's open
₹0
Previous close
₹0
VWAP
₹0
Lower price band
₹0
Upper price band
₹0

Today's Market Action

Its last traded stock price on BSE was 71.72 down by -2.32%. The total volume of shares on NSE and BSE combined was 0 shares. Its total combined turnover was Rs 0.00 crores.

Ishita Drugs Industries Ltd Medium and Long Term Market Action

The stock price of Ishita Drugs Industries Ltd is down by -100% over the last one month. Don't forget to check the full stock price history in the table below.

Ishita Drugs Industries Ltd Fundamentals

Market Cap (Cr): 21.4
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

Ishita Drugs Industries Ltd Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

Ishita Drugs Industries Ltd Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About Ishita Drugs Industries Ltd

Data not available.

Ishita Drugs Industries Ltd FAQ's

What is Share Price of Ishita Drugs Industries Ltd?

What is the Market Cap of Ishita Drugs Industries Ltd?

What is PE Ratio of Ishita Drugs Industries Ltd?

What is PB Ratio of Ishita Drugs Industries Ltd?

What is the CAGR of Ishita Drugs Industries Ltd?

How to Buy Ishita Drugs Industries Ltd Share?

Financials

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

Great Cash Conversion of Profits
The business has a great cash conversion ratio since it is able to convert a signifant portion of operating earnings of 178.15% into operating cash flow. This implies a great working capital cycle and large cash flows for either funding growth or dividends. This shall positively impact shareholder returns.
Asset Light Business
The company operates a great asset light business with a high Asset turnover ratio of 18.26. A high asset turnover ratio is a great driver of RoE and can improve shareholder returns. A relatively higher asset turnover ratio also will result in lower dilution as the business grows its revenues as earnings.

Cons

Low Sustainable RoE
The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
Low Return on Capital Employed
The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
Highly Cyclical Industry
The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
Low Pricing Power & High Competition
The business has extremely low pricing power and is vulnerable to competitive pressure which can significantly impact shareholder returns.
Poor Corporate Governance
The general corporate governance standards of the company are poor which can negatively impact shareholder value and returns.

Valuation Analysis

Margin of safety
(17/11/2024)

101

Margin of Safety Index: High

0% People are bullish about Ishita Drugs Industries Ltd

0 % People are bearish about Ishita Drugs Industries Ltd

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %